
Mexedia S.p.A (ALMEX) | Financial Analysis & Statements
Mexedia S.p.A. | Mid-cap | Financial Services
Mexedia S.p.A. | Mid-cap | Financial Services
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
157.2M
Total Liabilities
116.8M
Shareholders Equity
40.7M
Debt to Equity
2.87
Cash Flow Metrics
Revenue & Profitability Trend
Mexedia S.p.A Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 72.9M | 323.9M | 140.9M | 131.8M | 134.1M |
Cost of Goods Sold | 65.5M | 301.6M | 129.1M | 121.6M | 127.2M |
Gross Profit | 7.4M | 22.2M | 11.8M | 10.2M | 6.9M |
Gross Margin % | 10.2% | 6.9% | 8.4% | 7.7% | 5.2% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 28.0M | 4.7M | 2.6M | 3.0M | - |
Other Operating Expenses | 810.0K | 257.0K | 77.0K | 22.0K | 1.6M |
Total Operating Expenses | 28.8M | 5.0M | 2.6M | 3.0M | 1.6M |
Operating Income | -24.9M | 12.8M | 8.4M | 6.9M | 5.2M |
Operating Margin % | -34.2% | 3.9% | 5.9% | 5.2% | 3.9% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | 0 |
Interest Expense | 2.9M | 4.8M | 3.0M | 2.8M | - |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -27.8M | 6.5M | 5.0M | 3.4M | 4.9M |
Income Tax | -1.2M | 2.0M | 520.0K | 481.0K | 968.7K |
Effective Tax Rate % | 0.0% | 31.0% | 10.5% | 14.0% | 19.7% |
Net Income | -26.7M | 4.5M | 4.4M | 3.0M | 3.9M |
Net Margin % | -36.6% | 1.4% | 3.1% | 2.2% | 2.9% |
Key Metrics | |||||
EBITDA | -23.6M | 12.3M | 8.0M | 6.4M | 5.3M |
EPS (Basic) | €-4.61 | €0.79 | €0.78 | €0.52 | €0.69 |
EPS (Diluted) | €-4.61 | €0.79 | €0.78 | €0.52 | €0.69 |
Basic Shares Outstanding | - | 5694050 | 5700000 | 5700000 | 5700000 |
Diluted Shares Outstanding | - | 5694050 | 5700000 | 5700000 | 5700000 |
Income Statement Trend
Mexedia S.p.A Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 1.7M | 548.0K | 2.7M | 5.6M | 4.5M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 73.1M | 90.4M | 28.7M | 16.0M | 19.0M |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | 795.0K | 252.0K | 120.7K |
Total Current Assets | 74.8M | 100.9M | 41.6M | 30.2M | 24.8M |
Non-Current Assets | |||||
Property, Plant & Equipment | 214.0K | 24.0K | 3.0K | 1.0K | - |
Goodwill | 131.6M | 123.3M | 110.1M | 110.0M | 296.7K |
Intangible Assets | 14.5M | 10.4M | 149.0K | - | 296.7K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 6.4M | 11.0K | 10.0K | - | - |
Total Non-Current Assets | 82.4M | 67.6M | 55.4M | 55.1M | 2.4M |
Total Assets | 157.2M | 168.5M | 96.9M | 85.3M | 27.2M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 59.2M | 56.8M | 4.1M | 2.7M | 8.9M |
Short-term Debt | 327.0K | 41.8M | 29.0M | 24.0M | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 787.0K | 424.0K | 109.0K | 230.0K | - |
Total Current Liabilities | 63.6M | 101.6M | 34.2M | 27.2M | 8.9M |
Non-Current Liabilities | |||||
Long-term Debt | 4.7M | - | - | - | 9.5M |
Deferred Tax Liabilities | 53.0K | 44.0K | 14.0K | 0 | - |
Other Non-Current Liabilities | 3.5M | - | - | 1.0K | 0 |
Total Non-Current Liabilities | 53.2M | 113.0K | 62.0K | 24.0K | 10.8M |
Total Liabilities | 116.8M | 101.7M | 34.3M | 27.3M | 19.7M |
Equity | |||||
Common Stock | 57.0M | 57.0M | 57.0M | 57.0M | 92.6K |
Retained Earnings | -18.6M | 8.0M | 5.6M | 1.0M | 5.4M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 40.7M | 66.8M | 62.7M | 58.0M | 7.5M |
Key Metrics | |||||
Total Debt | 5.0M | 41.8M | 29.0M | 24.0M | 9.5M |
Working Capital | 11.2M | -683.0K | 7.4M | 2.9M | 15.9M |
Balance Sheet Composition
Mexedia S.p.A Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -26.7M | 4.5M | 4.4M | 3.0M | 4.3M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 31.5M | -60.6M | -8.4M | -24.7M | -2.4M |
Operating Cash Flow | 7.1M | -48.6M | -913.0K | -19.0M | 1.9M |
Investing Activities | |||||
Capital Expenditures | -151.0K | 6.0K | 6.0K | -79.0K | - |
Acquisitions | - | - | - | - | - |
Investment Purchases | -6.0M | -611.0K | -125.0K | 0 | -4.4K |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -6.1M | -1.6M | -119.0K | -79.0K | -4.4K |
Financing Activities | |||||
Share Repurchases | - | 0 | - | - | -1.1M |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 5.0M | 12.8M | 5.0M | 24.0M | 8.2M |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | 5.5M | 25.5M | 10.0M | 103.1M | 15.1M |
Free Cash Flow | 1.6M | -10.6M | -2.2M | -73.4M | -2.4M |
Net Change in Cash | 6.5M | -24.7M | 9.0M | 84.0M | 17.0M |
Cash Flow Trend
Mexedia S.p.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
8.59
Price to Book
4.65
Price to Sales
3.41
PEG Ratio
-0.01
Profitability Ratios
Profit Margin
-36.57%
Operating Margin
-68.00%
Return on Equity
-49.57%
Return on Assets
-9.47%
Financial Health
Current Ratio
1.12
Debt to Equity
0.80
Beta
-0.90
Per Share Data
EPS (TTM)
€-3.52
Book Value per Share
€8.31
Revenue per Share
€12.79
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
almex | 248.3M | 8.59 | 4.65 | -49.57% | -36.57% | 0.80 |
Amundi S.A | 13.3B | 8.00 | 1.11 | 14.23% | 24.40% | 168.82 |
Compagnie du | 6.1B | 141.43 | 1.12 | 0.76% | 128.75% | 0.73 |
Idi | 560.8M | 28.58 | 0.81 | 2.75% | 55.88% | 8.32 |
ABC Arbitrage S.A | 366.2M | 13.53 | 2.20 | 16.80% | 52.14% | 2.47 |
Wendel SE | 4.0B | 13.96 | 1.23 | 5.96% | 3.56% | 130.55 |
Financial data is updated regularly. All figures are in the company's reporting currency.